Chimeric Therapeutics Limited
CHMMF
$0.001
-$0.029-96.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -931.20K | -957.50K | -4.93M | -4.92M | 796.40K |
| Total Depreciation and Amortization | 158.60K | 163.10K | 196.10K | 195.70K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.60K | -93.20K | 3.27M | 3.26M | -2.32M |
| Change in Net Operating Assets | -- | -- | 527.80K | 526.70K | -- |
| Cash from Operations | -863.20K | -887.50K | -941.30K | -939.40K | -1.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.50K | 8.70K | -7.70K | -7.70K | 7.60K |
| Cash from Investing | 8.50K | 8.70K | -7.70K | -7.70K | 7.60K |
| Total Debt Issued | 781.00K | 781.00K | -- | -- | -- |
| Total Debt Repaid | -824.00K | -824.00K | -683.50K | -683.50K | -455.00K |
| Issuance of Common Stock | 2.50M | 2.50M | 2.09M | 2.09M | 3.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -162.40K | -162.40K | -209.20K | -209.20K | -394.10K |
| Cash from Financing | 1.50M | 1.54M | 786.40K | 784.80K | 1.91M |
| Foreign Exchange rate Adjustments | 16.00K | 16.40K | 7.00K | 7.00K | -16.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 656.50K | 675.10K | -155.70K | -155.30K | 378.90K |